0001437749-23-025476.txt : 20230908
0001437749-23-025476.hdr.sgml : 20230908
20230908154034
ACCESSION NUMBER: 0001437749-23-025476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230907
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schoenberg Mark
CENTRAL INDEX KEY: 0001763581
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 231245146
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA TA ASIYA STREET
CITY: RA ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-09-07
0001668243
UroGen Pharma Ltd.
URGN
0001763581
Schoenberg Mark
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Chief Medical Officer
0
Restricted Stock Units
2023-09-07
4
A
0
5000
0
A
Ordinary Shares
5000
5000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026
/s/ Jason Smith, Attorney-in-Fact
2023-09-08